Yan M, Wu S, Wang Y, Liang M, Wang M, Hu W, Yu G, Mao Z, Huang F, Zhou J (2024) Recent progress of supramolecular chemotherapy based on host–guest interactions. Adv Mater 36:2304249

Debaugnies M, Rodríguez-Acebes S, Blondeau J, Parent M-A, Zocco M, Song Y, de Maertelaer V, Moers V, Latil M, Dubois C, Coulonval K, Impens F, Van Haver D, Dufour S, Uemura A, Sotiropoulou PA, Méndez J, Blanpain C (2023) RHOJ controls EMT-associated resistance to chemotherapy. Nature 616(7955):168–175

Article  CAS  PubMed  PubMed Central  Google Scholar 

Albert A (1958) Chemical aspects of selective toxicity. Nature 182(4633):421–423

Article  CAS  PubMed  Google Scholar 

Fralish Z, Chen A, Khan S, Zhou P, Reker D (2024) The landscape of small-molecule prodrugs. Nat Rev Drug Discov 23(5):365–380

Article  CAS  PubMed  Google Scholar 

Fu Q, Shen S, Sun P, Gu Z, Bai Y, Wang X, Liu Z (2023) Bioorthogonal chemistry for prodrug activation in vivo. Chem Soc Rev 52(22):7737–7772

Article  CAS  PubMed  Google Scholar 

He X, Li J, Liang X, Mao W, Deng X, Qin M, Su H, Wu H (2024) An all-in-one tetrazine reagent for cysteine-selective labeling and bioorthogonal activable prodrug construction. Nat Commun 15(1):2831

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Y, Chen W, Wang C, Xing D (2024) Nanozyme-activating prodrug therapies: a review. Chin Chem Lett 35(2):109096

Article  CAS  Google Scholar 

Yao D, Wang Y, Bian K, Zhang B, Wang D (2023) A self-cascaded unimolecular prodrug for pH-responsive chemotherapy and tumor-detained photodynamic-immunotherapy of triple-negative breast cancer. Biomaterials 292:121920

Article  CAS  PubMed  Google Scholar 

Zeisel L, Felber JG, Scholzen KC, Schmitt C, Wiegand AJ, Komissarov L, Arnér ESJ, Thorn-Seshold O (2024) Piperazine-fused cyclic disulfides unlock high-performance bioreductive probes of thioredoxins and bifunctional reagents for thiol redox biology. J Am Chem Soc 146(8):5204–5214

Article  CAS  PubMed  Google Scholar 

Du C, Wang C, Jiang S-H, Zheng X, Li Z, Yao Y, Ding Y, Chen T, Yi H (2023) pH/GSH dual-responsive supramolecular nanomedicine for hypoxia-activated combination therapy. Biomater Sci 11(16):5674–5679

Article  CAS  PubMed  Google Scholar 

Long K, Lv W, Wang Z, Zhang Y, Chen K, Fan N, Li F, Zhang Y, Wang W (2023) Near-infrared light-triggered prodrug photolysis by one-step energy transfer. Nat Commu 14(1):8112

Article  CAS  Google Scholar 

Fu Q, Gu Z, Shen S, Bai Y, Wang X, Xu M, Sun P, Chen J, Li D, Liu Z (2024) Radiotherapy activates picolinium prodrugs in tumours. Nat Chem 16:1348–1356

Subbaiah MAM, Rautio J, Meanwell NA (2024) Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates. Chem Soc Rev 53(4):2099–2210

Article  CAS  PubMed  Google Scholar 

Li X, Gao Y, Li H, Majoral J-P, Shi X, Pich A (2023) Smart and bioinspired systems for overcoming biological barriers and enhancing disease theranostics. Prog Mater Sci 140:101170

Article  CAS  Google Scholar 

Fu Q, Shen S (2023) Bioorthogonal chemistry for prodrug activation in vivo. Chem Soc Rev 52(22):7737–7772

Article  CAS  PubMed  Google Scholar 

Xie A, Hanif S, Ouyang J, Tang Z, Kong N, Kim NY, Qi B, Patel D, Shi B, Tao W (2020) Stimuli-responsive prodrug-based cancer nanomedicine. EBioMedicine 56:102821

Article  PubMed  PubMed Central  Google Scholar 

Chang M, Gao F, Pontigon D, Gnawali G, Xu H, Wang W (2023) Bioorthogonal PROTAC prodrugs enabled by on-target activation. J Am Chem Soc 145(25):14155–14163

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Cui H, Zhang R, Zhang H, Huang W (2021) Nanoparticulation of prodrug into medicines for cancer therapy. Adv Sci 8(18):2101454

Article  CAS  Google Scholar 

Kyu Shim M, Yang S, Sun I-C, Kim K (2022) Tumor-activated carrier-free prodrug nanoparticles for targeted cancer immunotherapy: preclinical evidence for safe and effective drug delivery. Adv Drug Deliv Rev 183:114177

Article  CAS  PubMed  Google Scholar 

Ji X, Pan Z, Yu B, De La Cruz LK, Zheng Y, Ke B, Wang B (2019) Click and release: bioorthogonal approaches to “on-demand” activation of prodrugs. Chem Soc Rev 48(4):1077–1094

Article  CAS  PubMed  Google Scholar 

Zhang Q, Kuang G, Li W, Wang J, Ren H, Zhao Y (2023) Stimuli-responsive gene delivery nanocarriers for cancer therapy. Nano-Micro Lett 15(1):44

Article  Google Scholar 

Zhang Q, Kuang G, Wang L, Fan L, Zhao Y (2024) Tailoring drug delivery systems by microfluidics for tumor therapy. Mater Today 73:151–178

Article  Google Scholar 

Zhang X, Tang D, Xiao H, Li B, Shang K, Zhao D (2025) Activating the cGAS-STING pathway by manganese-based nanoparticles combined with platinum-based nanoparticles for enhanced ovarian cancer immunotherapy. ACS Nano 19(4):4346–4365

Article  PubMed  Google Scholar 

Huang H, Fang L, Wansapura J, Prior JL, Manion B, Xu B, Hongsermeier C, Gamadia N, Blasi N, Tang R, Egbulefu C, Shokeen M, Quirk JD, Achilefu S (2025) Cancer-targeted pro-theranostic bi-metallic organo-coordination nanoparticles. Theranostics 15(4):1205–1220

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang T, Shi X, Xu X, Zhang J, Ma Z, Meng C, Jiao D, Wang Y, Chen Y, He Z, Zhu Y, Liu H-N, Zhang T, Jiang Q (2025) Emerging prodrug and nano-drug delivery strategies for the detection and elimination of senescent tumor cells. Biomaterials 318:123129

Article  CAS  PubMed  Google Scholar 

Liu Y, Jiang M, Tu Y, Wang K, Zong Q, Yuan Y (2021) Time-programmed activation of dual polyprodrugs for synergistic cascade oxidation-chemotherapy. Biomaterials 278:121136

Article  CAS  PubMed  Google Scholar 

Deng C, Zhang J, Hu F, Han S, Zheng M, An F, Wang F (2024) A GSH-responsive prodrug with simultaneous triple-activation capacity for photodynamic/sonodynamic combination therapy with inhibited skin phototoxicity. Small 20(40):2400667

Article  CAS  Google Scholar 

Xiao D, Liu L, Xie F, Dong J, Wang Y, Xu X, Zhong W, Deng H, Zhou X, Li S (2024) Azobenzene-based linker strategy for selective activation of antibody–drug conjugates. Angew Chem Int Ed 63(16):e202310318

Article  CAS  Google Scholar 

Hao Y, Zhu W, Li J, Lin R, Huang W, Ain QU, Liu K, Wei N, Cheng D, Wu Y, Lv W (2024) Sustained release hypoxia-activated prodrug-loaded BSA nanoparticles enhance transarterial chemoembolization against hepatocellular carcinoma. J Controlled Release 372:155–167

Article  CAS  Google Scholar 

Hou D-Y, You Q, Zhang P, Li X-P, Wu J-C, Wang Y, You H-H, Lv M-Y, Wu G, Liu X, Guo P, Cheng D-B, Chen X, Xu W (2024) Cascade-activatable nanoprodrug system augments sonochemotherapy of bladder cancer. ACS Nano 18(52):35507–35519

Article  CAS  Google Scholar 

Ge L, Tang Y, Wang C, Chen J, Mao H, Jiang X (2024) A light-activatable theranostic combination for ratiometric hypoxia imaging and oxygen-deprived drug activity enhancement. Nat Commun 15(1):153

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beharry AA, Woolley GA (2011) Azobenzene photoswitches for biomolecules. Chem Soc Rev 40(8):4422–4437

Article  CAS  PubMed  Google Scholar 

Irie M (2000) Diarylethenes for memories and switches. Chem Rev 100(5):1685–1716

Article  CAS  PubMed  Google Scholar 

Szymański W, Beierle JM, Kistemaker HAV, Velema WA, Feringa BL (2013) Reversible photocontrol of biological systems by the incorporation